Cargando…
Quality by Design Applied Development of Immediate-Release Rabeprazole Sodium Dry-Coated Tablet
The aim of this study was to develop immediate-release oral rabeprazole sodium tablets with rapid efficacy and gastric stability for the treatment of gastroesophageal reflux disease. Rabeprazole sodium is a commonly prescribed proton pump inhibitor; however, it is extremely unstable and degrades in...
Autores principales: | Lee, Sang-Ho, Kim, Joo-Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918775/ https://www.ncbi.nlm.nih.gov/pubmed/33673019 http://dx.doi.org/10.3390/pharmaceutics13020259 |
Ejemplares similares
-
Rabeprazole sodium delayed-release multiparticulates: Effect of enteric coating layers on product performance
por: Tirpude, Rakesh N., et al.
Publicado: (2011) -
Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach
por: Kim, Hyeon-A, et al.
Publicado: (2022) -
Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole
por: Bae, Sungyeun, et al.
Publicado: (2023) -
Formulation and evaluation of sustained release matrix tablet of rabeprazole using wet granulation technique
por: Khan, Ruqaiyah, et al.
Publicado: (2014) -
Validation and Application of a New Reversed Phase HPLC Method for In Vitro Dissolution Studies of Rabeprazole Sodium in Delayed-Release Tablets
por: Nawaz, Md. Saddam
Publicado: (2013)